Cargando…
Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386327/ https://www.ncbi.nlm.nih.gov/pubmed/34497751 http://dx.doi.org/10.2478/jtim-2021-0024 |
_version_ | 1783742238619074560 |
---|---|
author | Karauzum, Irem Karauzum, Kurtulus Acar, Burak Hanci, Kaan Bildirici, Halil ibrahim Ulas Kilic, Teoman Ural, Ertan |
author_facet | Karauzum, Irem Karauzum, Kurtulus Acar, Burak Hanci, Kaan Bildirici, Halil ibrahim Ulas Kilic, Teoman Ural, Ertan |
author_sort | Karauzum, Irem |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS). METHODS: A total of 873 patients were assessed. LMR was calculated via dividing lymphocyte count by monocyte count. RESULTS: LMR was significantly lower in the with-CIN group. ROC analysis showed that the LMR ratios <2.52 predicted CIN development with sensitivity of 66.3% and specificity of 55.8%. Multivariate analysis showed that eGFR, admission glucose, and LMR were independent predictors of CIN in patients with ACS. CONCLUSION: LMR is an easily accessible marker and could be used as a predictor of CIN in patients with ACS undergoing percutaneous coronary intervention. |
format | Online Article Text |
id | pubmed-8386327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-83863272021-09-07 Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome Karauzum, Irem Karauzum, Kurtulus Acar, Burak Hanci, Kaan Bildirici, Halil ibrahim Ulas Kilic, Teoman Ural, Ertan J Transl Int Med Original Article BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS). METHODS: A total of 873 patients were assessed. LMR was calculated via dividing lymphocyte count by monocyte count. RESULTS: LMR was significantly lower in the with-CIN group. ROC analysis showed that the LMR ratios <2.52 predicted CIN development with sensitivity of 66.3% and specificity of 55.8%. Multivariate analysis showed that eGFR, admission glucose, and LMR were independent predictors of CIN in patients with ACS. CONCLUSION: LMR is an easily accessible marker and could be used as a predictor of CIN in patients with ACS undergoing percutaneous coronary intervention. Sciendo 2021-07-09 /pmc/articles/PMC8386327/ /pubmed/34497751 http://dx.doi.org/10.2478/jtim-2021-0024 Text en © 2021 Irem Karauzum et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Original Article Karauzum, Irem Karauzum, Kurtulus Acar, Burak Hanci, Kaan Bildirici, Halil ibrahim Ulas Kilic, Teoman Ural, Ertan Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title | Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title_full | Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title_fullStr | Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title_full_unstemmed | Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title_short | Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome |
title_sort | predictive value of lymphocyte-to-monocyte ratio in patients with contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386327/ https://www.ncbi.nlm.nih.gov/pubmed/34497751 http://dx.doi.org/10.2478/jtim-2021-0024 |
work_keys_str_mv | AT karauzumirem predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT karauzumkurtulus predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT acarburak predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT hancikaan predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT bildiricihalilibrahimulas predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT kilicteoman predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome AT uralertan predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome |